Answers are grounded in this paper and cite their sources.
Multicenter, double-blind trial shows improved hair regrowth with topical GT20029 in male patients, suggesting therapeutic potential in androgenetic alopecia.
Topical GT20029 demonstrated significant efficacy in hair regrowth with good tolerability. Further studies are warranted to confirm its therapeutic potential in AGA.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: